William Florence, Acting Branch Chief for Vaccines in the Translational Medical Division at the Defense Threat Reduction Agency, Will Present on “Current Biodefense Vaccine Programs and Challenges” at
Rick King, Vice President of Vaccine Design at the International Aids Vaccine Initiative, Will Present on “New Approaches to HIV Vaccine Design” at GTC’s 11th Vaccines Research & Development: All Thin
Protochips today announced that it has been selected to receive a 2013 Tibbetts Award, which is based on several factors, including the economic impact of the technological innovations, overall busine
Maureen Beresini, Senior Scientist at Genentech, will present on “From HTS to Mechanism: Kinase Screening Strategies That Maximize Hit Value” at the 8th Protein Kinases in Drug Discovery Conference on
David Cheresh, Distinguished Professor and Vice-Chair for Research and Development at the University of California San Diego, will give a keynote presentation at the 8th Protein Kinases in Drug Discov
From May 1st 2013, BBI Solutions is the new name for four core business entities of The BBI Group as it establishes a centralised solution for diagnostic critical reagents and development services.
AnaSpec is pleased to announce the recent release of two rabbit polyclonal antibodies - Anti-Tau antibody (GlcNAc Ser 400) and Anti-Tau antibody (Ser 400). In addition to the new antibodies, five new
.gif)
